NCT04653051

Brief Summary

The study is a single-center, retrospective, non-randomized, non-controlled and consecutive series post-market study. The purpose of this study is to confirm safety, performance and clinical benefits of the DVR Plates. The primary objective is the assessment of performance by analyzing fracture healing. The secondary objective is the assessment of safety by recording and analyzing the incidence and frequency of complications and adverse events. Patients' outcomes will also be assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
111

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Mar 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 19, 2020

Completed
15 days until next milestone

First Posted

Study publicly available on registry

December 4, 2020

Completed
3 months until next milestone

Study Start

First participant enrolled

March 12, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 3, 2021

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 15, 2022

Completed
2 years until next milestone

Results Posted

Study results publicly available

November 20, 2024

Completed
Last Updated

November 20, 2024

Status Verified

September 1, 2024

Enrollment Period

7 months

First QC Date

November 19, 2020

Results QC Date

December 20, 2022

Last Update Submit

September 19, 2024

Conditions

Keywords

Medical DevicePerformanceSafetyClinical BenefitsPost-Market Clinical Follow-Up Study

Outcome Measures

Primary Outcomes (1)

  • Fracture Healing Based on Clinical Measures and X-rays

    Fracture healing will be evaluated by x-rays and clinical measures (no pain at fracture site)

    Mean time of 3.8 years after the surgery

Secondary Outcomes (2)

  • Product Safety Based on Complications

    Mean time of 3.8 years after surgery

  • Patient's Outcomes Were Also Assessed

    Mean time of 3.8 years after surgery

Study Arms (1)

Patients who received DVR Plating System

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients must have received one of the DVR Plates and who meet all of the inclusion and none of the exclusion criteria.

You may qualify if:

  • All subjects must have been implanted with one of the DVR Plates according to the approved indications.

You may not qualify if:

  • Off-label use.
  • Cases where there is an active infection.
  • Conditions which tend to retard healing such as, blood supply limitations, previous infections, etc.
  • Insufficient quantity or quality of bone to permit stabilization of the fracture.
  • Conditions that restrict the patient's ability or willingness to follow postoperative instructions during the healing process.
  • Foreign body sensitivity - where material sensitivity is suspected, appropriate tests should be conducted and sensitivity ruled out prior to implantations.
  • Cases where the implant(s) would cross open epiphyseal plates in skeletally immature patients.
  • Cases with malignant primary or metastatic tumors which preclude adequate bone support or screw fixations, unless supplemental fixation or stabilization methods are utilized.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Southampton General Hospital

Southampton, United Kingdom

Location

MeSH Terms

Conditions

Wrist Fractures

Condition Hierarchy (Ancestors)

Wrist InjuriesArm InjuriesWounds and InjuriesFractures, Bone

Limitations and Caveats

The limitations of this study are that it was retrospective, over the pandemic and required extensive hours of discussion and contacting of patients which took extended time.

Results Point of Contact

Title
Georgia Tsapara
Organization
Zimmer Biomet

Study Officials

  • Hassan Achakri

    Zimmer Biomet

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
GT60
Restrictive Agreement
Yes

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 19, 2020

First Posted

December 4, 2020

Study Start

March 12, 2021

Primary Completion

October 3, 2021

Study Completion

November 15, 2022

Last Updated

November 20, 2024

Results First Posted

November 20, 2024

Record last verified: 2024-09

Locations